hepatitis B

Dynavax: Let The Show Begin!
Seeking Alpha
Mon, 04/30/12 - 01:04 pm
Dynavax
Heplisav
GSK
hepatitis B
AstraZeneca
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Yahoo/BusinessWire
Sat, 11/5/11 - 02:46 pm
Viread
Gilead Sciences
hepatitis B
GlobeImmune, Gilead team up on hepatitis B treatment
Bizjournals.com
Tue, 10/25/11 - 09:21 am
Gilead
GlobeImmune
hepatitis B
Tarmogens
Amarillo Biosciences Issues Corporate Update
Yahoo/PR NewsWire
Sat, 10/15/11 - 11:40 am
Amarillo Biosciences
oral interferon
hepatitis C
hepatitis B
Dynavax says data shows hepatitis B vaccine Heplisav works on patients who are hard to treat
Yahoo/AP
Mon, 10/10/11 - 12:10 pm
hepatitis B
Dynavax
Heplisav
GSK
Engerix-B
Still Want to Be the Next Dendreon?
Motley Fool
Sat, 08/6/11 - 01:01 pm
Dendreon
Vertex Pharmaceuticals
Incivek
hepatitis B
Dynavax jumps 25% on FDA update
Marketwatch
Thu, 07/28/11 - 01:46 pm
FDA
Dynavax
vaccines
Heplisav
hepatitis B
Dynavax plunges 16% on mixed study results
Marketwatch
Wed, 07/20/11 - 12:52 pm
Dynavax
vaccines
hepatitis B
Heplisav
Dynavax Technologies: Heplisav Trial Results to Be Big Catalyst for Stock
Seeking Alpha
Tue, 07/19/11 - 06:13 pm
Heplisav
Dynavax
vaccines
hepatitis B
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
Yahoo/BusinessWire
Sat, 10/30/10 - 12:22 pm
Viread
Gilead Sciences
hepatitis B
Abbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment
Thu, 09/2/10 - 03:05 pm
Abbott Laboratories
hepatitis B
Dynavax gets grant for hepatitis B work
Bizjournals.com
Tue, 08/31/10 - 12:11 pm
Dynavax
hepatitis B
grants
Generic Risk For Gilead's Hepsera
Yahoo/Zacks.com
Fri, 08/20/10 - 10:56 am
Gilead Sciences
Hepsera
generics
Bristol-Myers Squibb
Merck
hepatitis B
Merck Still Struggles With Adult Hepatitis B Vaccine
Pharmalot
Fri, 07/30/10 - 10:58 am
Merck
hepatitis B
vaccines
Recombivax
Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
PR NewsWire
Thu, 06/17/10 - 10:15 am
Kun Run Biotechnology
Entecavir
hepatitis B
Analyst says Dynavax Technologies hepatitis B vaccine Heplisav should be approved in 2012
Yahoo/AP
Fri, 05/14/10 - 08:58 am
Dynavax
Heplisav
vaccines
hepatitis B
Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market
PR-CANADA
Sun, 04/25/10 - 11:45 am
Biostar Pharmaceuticals
hepatitis B
Dynavax touts safety of hepatitis vaccine
Bizjournals.com
Wed, 03/24/10 - 06:58 am
Dynavax
vaccines
Heplisav
hepatitis B
Dynavax hopes to submit Heplisav to FDA 6 months early
Bizjournals.com
Wed, 03/17/10 - 09:41 am
Dynavax
Heplisav
hepatitis B
Merck
vaccines
FDA

Pages